SWM
BIIB icon

SeaCrest Wealth Management’s Biogen BIIB Stock Holding History

SeaCrest Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,430
Closed -$292K – 720
2022
Q2 		$292K Buy
1,430
+84
+6% +$17.2K 0.04% 472
2022
Q1 		$283K Sell
1,346
-49
-4% -$10.7K 0.03% 528
2021
Q4 		$335K Sell
1,395
-957
-41% -$246K 0.04% 476
2021
Q3 		$666K Buy
2,352
+58
+3% +$19K 0.08% 257
2021
Q2 		$794K Buy
+2,294
New +$695K 0.1% 228
2019
Q2 		– Sell
-390
Closed -$92K – 660
2019
Q1 		$92K Buy
390
+166
+74% +$52.3K 0.02% 717
2018
Q4 		$67K Sell
224
-644
-74% -$206K 0.01% 798
2018
Q3 		$307K Sell
868
-278
-24% -$95.7K 0.05% 382
2018
Q2 		$333K Sell
1,146
-644
-36% -$181K 0.06% 352
2018
Q1 		$490K Buy
1,790
+208
+13% +$64.6K 0.09% 241
2017
Q4 		$504K Buy
+1,582
New +$508K 0.09% 238

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SeaCrest Wealth Management's BIIB Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Biogen (BIIB) in Q3 2022, closing a stake of 1,430 shares — an estimated $292K sold.

SeaCrest Wealth Management first reported a position in BIIB in Q4 2017 and held it in 11 quarters. The position peaked at $794K in Q2 2021. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 1,430 Biogen shares in Q3 2022, an estimated $292K.
  • SeaCrest Wealth Management first reported a position in Biogen in Q4 2017 and held it in 11 quarters.
  • SeaCrest Wealth Management's Biogen position peaked at $794K in Q2 2021.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.